Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative
Journal of Cystic Fibrosis · 2024-11 · 23 (6) · 1159-1162
DOI: 10.1016/j.jcf.2024.03.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2024-11. Verfasst von Jonathan D Cogen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, USA. Electronic address: j…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Antimicrobial Stewardship, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Antibiotics are frequently utilized for cystic fibrosis (CF)-related pulmonary exacerbation treatment. The antibiotic spectrum index (ASI) is an antimicrobial stewardship tool developed to compare the relative breadth of individual antibiotics. This study aimed to create two expanded CF-specific ASI scoring indices for use in antimicrobial stewardship research and clinical care. The first scoring index expanded the original ASI to include bacterial microorganisms common to CF airway infections (CF-ASI). The second scoring system only included scores for bacterial microorganisms classically identified in CF airway infections (CF-sASI). Sixty-two antibiotics were evaluated and included in the updated ASIs. When multiple antibiotics are prescribed, we proposed using an additive ASI approach whereby the sum of the individual prescribed antibiotic scores represents the total ASI score. The application of CF-focused ASIs into CF research and stewardship programs can help to optimize antibiotic benefits, minimize harms and allow for increased sustainability of antibiotic use in CF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, USA. Electronic address: jonathan.cogen@seattlechildrens.org.
- Division of Pulmonary and Sleep Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington, USA; Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Ch…
- Department of Pharmacy, Seattle Children's Hospital, USA.
- Pediatrics, Case Western Reserve University School of Medicine, Cleveland OH, USA.
- Division of Infectious Diseases, Children's Hospital of Philadelphia and Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
- Division of Infectious Diseases, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, WA, USA.
Zitieren
APA
Cogen, J. D., Heltshe, S. L., Brothers, A. W., VanDevanter, D. R., Gerber, J. S., Kronman, M. P., & Somayaji, R. (2024). Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative. Journal of Cystic Fibrosis, 23(6), 1159-1162. https://doi.org/10.1016/j.jcf.2024.03.004
Vancouver
Cogen JD, Heltshe SL, Brothers AW, VanDevanter DR, Gerber JS, Kronman MP, et al. Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative. Journal of Cystic Fibrosis. 2024;23(6):1159-1162. doi:10.1016/j.jcf.2024.03.004
BibTeX
@article{Cogen2024,
author = {Cogen, Jonathan D and Heltshe, Sonya L and Brothers, Adam W and VanDevanter, Donald R and Gerber, Jeffrey S and Kronman, Matthew P and Somayaji, Ranjani},
title = {Creation of a CF-specific antibiotic spectrum index (ASI) as an antimicrobial stewardship initiative},
journal = {Journal of Cystic Fibrosis},
year = {2024},
volume = {23},
number = {6},
pages = {1159--1162},
doi = {10.1016/j.jcf.2024.03.004}
}
EUVIMED